Evidence map›Paper›PMID 39398908›Full record

ArticleInternational cancer conference journal2024

A rare case of synchronous bilateral ovarian cancer with combined clear cell and mucinous carcinomas and brain metastases.

Keita Hasegawa, Tomoko Yoshihama, Mio Takahashi, Norihiko Nakazato, Yukako Suga, Yoko Iguchi, Yoshito Ueyama, Masaaki Itoh, Nobuyuki Sakurai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International cancer conference journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Keita HasegawaDepartment of Obstetrics and Gynecology, Inagi Municipal Hospital, 1171, Omaru, Inagi, Tokyo, 206-0801 Japan.
Tomoko YoshihamaDepartment of Obstetrics and Gynecology, Inagi Municipal Hospital, 1171, Omaru, Inagi, Tokyo, 206-0801 Japan.
Mio TakahashiDepartment of Obstetrics and Gynecology, Inagi Municipal Hospital, 1171, Omaru, Inagi, Tokyo, 206-0801 Japan.
Norihiko NakazatoDepartment of Obstetrics and Gynecology, Inagi Municipal Hospital, 1171, Omaru, Inagi, Tokyo, 206-0801 Japan.
Yukako SugaDepartment of Obstetrics and Gynecology, Inagi Municipal Hospital, 1171, Omaru, Inagi, Tokyo, 206-0801 Japan.
Yoko IguchiDepartment of Obstetrics and Gynecology, Inagi Municipal Hospital, 1171, Omaru, Inagi, Tokyo, 206-0801 Japan.
Yoshito UeyamaDepartment of Pathology, Inagi Municipal Hospital, 1171, Omaru, Inagi, Tokyo, 206-0801 Japan.
Masaaki ItohDepartment of Obstetrics and Gynecology, Inagi Municipal Hospital, 1171, Omaru, Inagi, Tokyo, 206-0801 Japan.
Nobuyuki SakuraiDepartment of Obstetrics and Gynecology, Inagi Municipal Hospital, 1171, Omaru, Inagi, Tokyo, 206-0801 Japan.ORCID 0000-0002-7766-6105

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although ovarian cancer is generally unilateral, a few cases of bilateral ovarian cancer have been reported, most of which originate from metastases of unilateral ovarian cancer. However, synchronous primary bilateral ovarian cancer (SBOC), comprising two different histological types of ovarian cancer, is extremely rare, with limited reports on its clinical course and prognosis. Herein, we report the case of a 56-year-old postmenopausal Japanese woman with stage IVB SBOC with combined left ovarian clear cell and right ovarian mucinous carcinomas. The patient underwent surgery and received postoperative taxane/platinum-based chemotherapy, which temporarily reduced the tumor size. However, an increase in tumor size and brain metastases were subsequently identified. Treatment was accordingly discontinued, and the patient died of the disease 12 months after diagnosis. In this case report, we detail the clinical course of a case of SBOC. To the best of our knowledge, this is the first report of SBOC with combined histological types of clear cell and mucinous carcinomas, and it is also the first report of SBOC with the eventual discovery of brain metastases.

Indexed as

Brain metastasesClear cell carcinomaMucinous carcinomaSynchronous bilateral ovarian cancer

Identifiers

PMID39398908
PMCPMC11464955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.